Pancreatic ductal adenocarcinoma is one of the major causes of cancer mortality in the industrialized world, having among the poorest prognosis of any malignancy. Mutations or alterations in the p53 tumor suppressor gene/protein are observed in 50 ± 70% of these cancers, yet little information is available regarding the phenotypic eects of restoration of wild-type (wt) p53 function in pancreatic ductal carcinoma cells. The consequences of stable reintroduction of wt p53 on apoptosis and dierentiation was examined in a poorly dierentiated pancreatic carcinoma cell line (Panc-1), possessing only mutant (mt) p53 (codon 273 mutation). Cells were transfected with a temperature-sensitive mouse p53 val135 (tsp53) vector under additional control of a geneticallymodi®ed metallothionein promoter. This tsp53 has a`mt' phenotype at 37.58C, and a`wt' phenotype at 32.58C and the presence of 100 mM ZnCl 2 . Stable expression of wt p53 caused upregulation of the p21/WAF1 gene, and G 1 growth arrest as shown by¯ow cytometry and BrdU labeling. Additionally, apoptosis was induced 8 ± 12 postinduction in the majority of the cells (60 ± 70%), as demonstrated by morphological changes, in situ TdT labeling and internucleosomal laddering. However, a subpopulation (30%) of the transfectants survived this apoptotic fate. Unlike the epithelial parental Panc-1 cells, these cells exhibited the appearance of a neuroendocrine-like phenotype with extensive branch-like processes, and marked cytoplasmic and cytoskeletal immunostaining for tau-2, synaptophysin, and chromogranin A. These studies suggest that stable and regulated expression of wt p53 can have multiple phenotypic consequences (apoptosis and altered dierentiation to a neuroendocrine-like phenotype) in poorly-dierentiated pancreatic carcinoma cells.
Introduction
Pancreatic cancer is one of the most deadly forms of cancer. In the United States, this cancer ranks among the ®ve leading causes of death by a malignant disease (Hahn and Kern, 1995) . The absence of de®nitive precursor lesions to pancreatic adenocarcinoma, the aggressive nature of the cancer, and its diagnosis relatively late in the progression of the disease, have contributed to its high mortality (Murr et al., 1994) .
Despite its grim prognosis, relatively little progress has been made in understanding the molecular pathology of pancreatic cancer. In addition, what is known regarding the role of tumor suppressor gene abnormalities in pancreatic cancer is limited. The most frequently mutated tumor suppressor gene detected in all human cancers is the p53 gene (Zambetti and Levine, 1993) . Molecular and immunochemical studies from our laboratory (Ruggeri et al., 1997) and others (Redston et al., 1994; Pellegata et al., 1994; Barton et al., 1991; Weyrer et al., 1996) have revealed p53 mutations in 50 ± 70% of pancreatic ductal cancers, with a complex mutation spectra and an unusually high frequency of one to two base pair microdeletions (Ruggeri et al., 1997; Redston et al., 1994) . The p53 protein acts as a G 1 cell cycle checkpoint in response to cell stress or DNA damage. In cells or tissues subjected to U.V. or gamma irradiation, levels of the wild-type p53 protein are elevated post-translationally; this increase in the wild-type p53 protein is associated with a transient inhibition of DNA synthesis (Maltzman and Czyzyk, 1984; Kastan et al., 1991) . While the wild-type p53 halts the cell cycle in G 1 for DNA repair, the mutant fails to growth arrest cells in G 1 and the cell proceeds through G 1 to S phase.
Studies reintroducing wild-type p53 into cancer cells that have lost the expression of the p53 protein have shown a variety of eects. Consequences of p53 reintroduction in these studies include growth arrest (Diller et al., 1990; Mercer et al., 1990; Michalovitz et al., 1990) , terminal dierentiation (Yonish-Rouach et al., 1993) , or induction of the apoptotic pathway (Yonish-Rouach et al., 1991; Shaw et al., 1992) . These studies illustrate that the outcome of wild-type p53 reintroduction is not a predictable event but dependent on the cell system in which p53 is re-expressed.
Incorporation of wild-type p53 into transformed cell lines devoid of the normal p53 gene has been shown to induce apoptosis in several studies (Yonish-Rouach et al., 1991 , 1993 Shaw et al., 1992; Fujiwara et al., 1993) . Apoptosis induced by stable expression of wildtype p53 has been demonstrated in mouse myeloid leukemia cells (Yonish-Rouach et al., 1991 , 1993 , mouse T-cell lymphomas (Clarke et al., 1993) , murine and human melanomas (Cirielli et al., 1995) , human lung cancer spheroids (Fujiwara et al., 1993) , head and neck squamous cell carcinoma (Liu et al., 1994) , and colon carcinomas (Shaw et al., 1992) . These wild-type p53 induced eects are often cell-type dependent, and in¯uenced by the dierentiation state of the tumor cells. Moreover, cells vary in their threshold for induction of apoptosis. Upregulation of p53 may also play a role in cellular dierentiation. Studies using retinoic acid-induced dierentiating muscle cells show an early upregulation of p53, prior to the expression of dierentiation-speci®c genes (Halevy, 1993) . In addition, the transfection of wild-type p53 into cells have been shown to induce the dierentiation of a variety of cell types, including squamous cell carcinomas (Brenner et al., 1993) , teratocarcinomas (Kosaka et al., 1992) , osteosarcomas (Radinsky et al., 1994) , and hematopoietic precursor cells (Horii et al., 1992; Feinstein et al., 1992; Soddu et al., 1994) . Conversely, it has also been demonstrated that transfection of mutant p53 blocks dierentiation and facilitates malignant transformation in hematopoietic cells (Horii et al., 1992) .
Transfection studies examining the phenotypic consequences of wild-type p53 gene replacement on tumor growth in vitro and in vivo have been demonstrated in a number of human cancers (Shaw et al., 1992; Fujiwara et al., 1993) . However, to date, this has not been unequivocally demonstrated (Kimura et al., 1997) in a pancreatic ductal carcinoma cell model with cells possessing an endogenous mutant p53 despite the prevalence of p53 mutations in this cancer and its refractory response to most available treatment modalities. In this report, we describe the phenotypic consequences of stable and regulated expression of the wild-type p53 gene in poorly dierentiated pancreatic carcinoma cells, Panc-1, possessing an endogenous p53 mutation (codon 273 CGT?CAT (Redston et al., 1994; Ruggeri et al., 1992) ). Given the relatively high frequency of p53 mutations in this cancer, understanding the role wild-type p53 plays in the regulation of cellular growth, apoptosis, and cellular differentiation in pancreatic carcinoma is critical. We provide the ®rst evidence that stable and regulated expression of wild-type p53 in this tumor model has multiple phenotypic consequences: G 1 growth arrest and apoptosis in the majority (60 ± 70%) of tumor cells, and a stable non-reversible growth-arrested minority (30 ± 40%) of cells exhibiting morphologic and antigenic properties of a dierentiated neuroendocrine-like phenotype in vitro.
Results
Stable induction of wild-type Mtmp53ts-transfected Panc-1 clones induces growth arrest and apoptosis Sixty clones were isolated post calcium phosphate transfection and screened by PCR. Fifty clones showed evidence of an insert and 12 were selected to be screened for wild-type p53 protein production. Out of these 12, six demonstrated both the ability to express the exogenous wild-type p53 following induction (100 mM ZnCl 2 , 32.58C), and the absence of wild-type p53 gene expression under non-inducing conditions ( Figure 1a) . Three of these clones (tpc12, tpc37 and tpc47) were utilized, with each experiment performed in duplicate or triplicate for each clone. There was no statistical dierence in experimental outcome between the three clones in all analyses.
Immunohistochemical and immunoprecipitation/ Western blotting under inducing conditions revealed positive nuclear murine p53 staining and elevated levels of murine wild-type p53 protein, respectively, within the ®rst 2 h post-induction utilizing an antibody speci®c for wild-type p53 protein (Figure 1) . After a single induction of ZnCl 2 /32.58C, immunoreactivity for murine wild-type p53 remained detectable for over 24 h (Figure 1b) . Parental Panc-1 cells containing endogenous p53, and murine squamous cell carcinoma cell line containing a mutant p53 revealed the absence of immunoreactivity in these analyses (Figure 1a) . The functionality of the transfected wild-type p53 protein was demonstrated by elevated expression of p21/WAF1 protein in MTmp53ts transfectants following induction compared to basal levels observed in parental Panc-1 cells and non-induced clones (Figure 1c) .
In the absence of inducing stimuli (ZnCl 2 and 32.58C) or the presence of only one stimulus (ZnCl 2 or 32.58C), growth of Mtmp53ts-transfected Panc-1 cells exhibited a pattern comparable to that of parental Panc-1 cells or sham-transfected Panc-1 cells ( Figure  2a) . However, the clones incubated with ZnCl 2 at 32.58C were found to have a reduction in overall cell growth over the ®rst 48 h. The induced clonal population showed no recovery in cell numbers over the time course of the experiment, and exhibited a concomitant loss in viability as assessed by trypan blue uptake (Figure 2a ). Cell proliferation was measured by 5-bromo-2'-deoxy-uridine (BrdU) incorporation (Figure 2b) . It was observed that while the parental Panc-1 cells maintained a 48.9% (+1.1%) positive stain for BrdU, the induced clones revealed a marked decline in postive BrdU staining after 9 h. The growth arrest, shown here by reduced BrdU staining, has been shown to occur in other cell culture models as well after the incorporation of wild-type p53 (Diller et al., 1990; Gannon and Lane, 1991; Martinez et al., 1991; Mercer et al., 1990; Michalovitz et al., 1990) .
In order to determine the cell-cycle speci®c nature of p53-mediated growth arrest in induced MTmp53ts clones,¯ow cytometric analysis of propidium iodidestained DNA from clones, parental Panc-1 cells and controls (MTmp53ts clones without one or both inducing conditions) were conducted. In comparison to the Panc-1 clones and uninduced MTmp53ts clonal cells, the transfectants in the presence of ZnCl 2 (at 32.58C) showed a marked reduction in the G 2 peak with accumulation in G 1 . After 9 h post-induction, these induced clones produced a¯ow cytometric pattern indicative of a G 1 growth arrested state (data not shown).
To examine morphological changes in the wild-type p53 transfected cells under varying conditions, observations were made over a time-course of 2 days. In addition to the MTmp53ts transfected clones, parental Panc-1 cells were also induced. Parental cells and clones were also kept at 378C, both with and without ZnCl 2 induction. While control cells appeared relatively similar, the transfected clones showed gross morphological changes over the time course. At 8 h post induction, many of the cells developed irregular jagged borders. At 11 h, there was presence of both cell constriction and cellular blebbing. By 12 h post induction, a high percentage (60 ± 70%) of the cells were non-viable. These cells presented classical apoptotic histo-morphology: cell shrinkage, detachment from surrounding cells, and budding of cytoplasm (Figure 3 ) (Carson and Ribeiro, 1993) .
In addition to morphological observations, DNA was isolated from the dierent cell populations (parentals and transfected clones with or without induction stimuli) or cells were ®xed in situ and examined for double-stranded internucleosomal cleavage. Internucleosomal laddering was detected in situ utilizing a modi®cation of the TUNEL method (Gavrieli et al., 1992) . It was found that induced clones exhibited positive staining beginning approximately 8 h post induction, with the most abundant staining at 10 h. The percentage of positive staining cells then decreased to negligible levels by 18 h postinduction. There was no detectable staining in the parental Panc-1 cells under one or both inducing conditions (Figure 4) . DNA was collected at 10 and 24 h post induction; 10 hours corresponding to the highest levels of in situ staining. A DNA nucleosomal ladder could be visualized in MTmp53ts clones at 10 h post induction. This banding pattern was distinct from that seen with genomic DNA from proliferating Panc-1 cells at the same time points post-induction ( Figure 4 ).
Stable induction of wild-type p53 in MTmp53ts Panc-1 clones exhibit an altered phenotype in a subpopulation of cells
During the course of the wild-type p53 induction studies, a consistent and reproducible observation in all three clones utilized was the emergence of a small population of induced clonal cells that survived the apoptotic fate of the majority. They were growth arrested in the G 1 phase of the cell cycle and exhibited the absence of BrdU staining. In addition, the cells retained a functional MTmp53ts expression vector ( Figure 1c ). These cells were maintained in culture and observed over a 2 week period. At 48 h post induction, many of these survivors¯attened out and spread, appearing as`giant' cells, and exhibited unusual branch-like outgrowths ( Figure 3 ) which remained stable in culture over the 2 week observing period. Moreover, in addition to their viability and stability in vitro, restoration of non-inducing conditions (removal of 100 mM ZnCl 2 , 37.58C) failed to revert the cells back to the ductal epithelial phenotype of the parental Panc-1 cells. This suggests that this growtharrested branching phenotype is not reversible. Morphologically, these growth-arrested branching cells resemble neuroendocrine cells in culture (Eizenberg et al., 1996) , lending to speculation that a subpopulation of stably induced MTmp53ts Panc-1 clones may be dierentiating into neuroendocrine-like cells. Evidence exists in a number of mammalian species demonstrating the capacity of pancreatic ductular epithelial cells to dierentiate to a neuroendocrine cell phenotype (Rosenberg et al., 1996; Wang et al., 1995; Logsdon, 1995) . The potential role of wildtype p53 in regulation of this speci®c dierentiation process has not been addressed.
In order to further test that these cells indeed resemble neuroendocrine cells, immunohistochemical analyses of neuronal or neuroendocrine associated markers were conducted on induced MTmp53ts clones, parental Panc-1 cells and sham-transfected controls. These analyses revealed marked perinuclear and cytoplasmic immunostaining for tau-2 (an intermediate neuro®lament associated protein (Wang et al., 1993) , and intense cytoskeletal and cytoplasmic staining for synaptophysin and chromogranin A (neurosecretory granule glycoproteins (Ngsee et al., 1990; Taupenot et al., 1995) ) in induced MTmp53ts clones exhibiting this stable, branched-like phenotype. In contrast, immunostaining for these marker proteins was weak or absent in parental Panc-1 cells ( Figure  5a ). These analyses were subsequently con®rmed by Western blotting (Figure 5b) , revealing a dierential expression of these three neuroendocrine proteins in wild-type p53-induced clones compared to non-induced clones and parental Panc-1 cells. These data lend support to the possibility that stable induction of wildtype p53 in poorly dierentiated pancreatic carcinoma cells may be altering their dierentiative state to that of a neuroendocrine-like phenotype. The possibility that these branching, growth-arrested cells are demonstrating a senescent phenotype, or are produced as an artifact in response to the elevated zinc levels in the culture media was considered. Both possibilities are unlikely, however, because although the parental Panc-1 cells do show an occasional rare branching cell, these cells do not resemble the induced MTmp53ts clones in terms of the number and complexity of branched processes. However, in light of studies involving p53 and senescence, future experiments will be planned to examine senescence markers in this system. Evidence linking p53 and senescence include the observation that senescent ®broblasts contain more activated wild-type p53 as compared to lower passage cells (Atadja et al., 1995) , that cells containing mutant p53 exhibit a signi®cant increase in lifespan (Bond et al., 1995) , and that transfection of wild-type p53 into EJ bladder carcinoma cells induces a senescence phenotype (Sugrue et al., 1997) . The parental Panc-1 cells exhibited no toxic eects to zinc at the concentrations used in these studies based upon both cell morphology and cell growth characteristics in the presence of 100 mM ZnCl 2 and 32.58C (Figures 2 and 3) . Additionally, Panc-1 cells surviving treatment with 
Discussion
The present studies were undertaken to examine the consequences of stable and regulated expression of wild-type p53 into a pancreatic carcinoma cell line possessing only mutant endogenous p53 (codon 273, CGT?CAT) (Redson et al., 1994; Ruggeri et al., 1992) . The transfected clones utilized were shown to be a reliable model, with stable induction of mouse p53 after treatment with ZnCl 2 (100mM) at 32.58C, and the absence of leakiness of the transfected vector at 32.58C alone or at 378C in the presence of zinc (Figure 1) .
As a consequence of this stably overexpressed wildtype p53, the transfected cells showed an invariable pattern of growth arrest, with the majority of cells undergoing subsequent apoptosis. Furthermore, a consistently observed stable growth-arrested minority displaying a non-reversible phenotype may possibly be associated with altered cell dierentiation to a neuroendocrine-like phenotype.
It is not known whether this p53-dependent apoptosis occurring in 60 ± 70% of the cell population is a consequence of the induction of growth arrest, or if it is an independent process. The biological functioning of p53 makes it appear logical that the two events are connected. Since the same DNA damaging events activate either growth arrest or apoptosis it has been speculated that these two events are associated (Fisher, 1994) . In contrast, theories of dual pathways are supported by studies using M1 clone S6 myeloid Additionally, apoptosis can occur in experiments that inhibit the cell cycle via protein synthesis inhibition (Caelles et al., 1994) . These results support the idea that apoptosis and growth arrest are independent mechanisms. While our present study demonstrates both G 1 growth arrest and apoptosis in this speci®c model, it is not clear if these events are co-dependent or not. In fact, the growth arrest detected may be in speci®cally the surviving branch cells and may be a consequence of cells terminally dierentiating in response to over-expression of wild-type p53, as described in other systems (Shaulsky et al., 1991a,b) . Most of the studies linking p53 and cellular dierentiation have been done in hematopoietic cell types. For example, transfection and upregulation of wild-type p53 in a pre-B cell line, L12, advances the cells to a more dierentiated phenotype (Shaulsky et al., 1991a) . These transfected L12 cells express the dierentiation markers B cell speci®c antigen and immunoglobulin m heavy chain. In addition, both Friends erythroleukemia and K562 erythroid acute phase leukemic cell lines expressed hemoglobin when stably transfected with wild-type p53 (Feinstein et al., 1992; Johnson et al., 1993) . In both of these systems, this dierentiation process was coupled with apoptotic cell death (Feinstein et al., 1992; Johnson et al., 1993) . Moreover, reintroduction of wild-type p53 has been shown to induce dierentiation in non-hematopoietic cell types. In SqCC/y1 head and neck squamous carcinoma cells, expression of wild-type p53 increased expression of proteins required for the corni®ed cell envelope (keratinocyte-speci®c transglutaminase 1 and involucrin) in the absence of growth arrest (Brenner et al., 1993) . Similarly, metastatic osteogenic sarcoma cells (SAOS-LM2), transfected with and expressing wild-type p53, exhibited increased production of osteoid matrix when cells were injected in nude mice (Radinsky et al., 1994) .
While experiments examining pancreatic differentiation and p53 are extremely limited, there are numerous studies that describe pancreatic dierentiation and transdierentiation. Models utilizing hamsters with partially obstructed pancreatic ducts by cellophane wrapping (Rosenberg et al., 1996) or duct ligated adult rats (Wang et al., 1995) reveal a transdierentiation of ductal epithelia to an islet cell phenotype. In addition, there are many examples of in vivo and in vitro exocrine pancreatic transdierentiation of acinar cells to ducts, as well as ductal to acinar cells (see review Hall and Lemoine, 1993) . Furthermore, pancreatic ducts can transdierentiate to a non-pancreatic cell phenotype, including hepatocytes (Makino et al., 1990; Hall and Lemoine, 1993) . These studies illustrate the plasticity of pancreatic cells derived from developing and adult tissues. There are limited studies examining regulation of dierentiation in the pancreatic carcinoma cell-line, Panc-1. Treatment of Panc-1 cells with all-transretinoic acid or sodium butyrate was shown to be growth-inhibitory (Bold et al., 1996; Mullins et al., 1991) . In addition, sodium butyrate and transfection of an exogenous Muc-1 gene also induced ultrastructural changes, including increased amounts of rough endoplastic reticulum and Golgi, suggestive of a more dierentiated phenotype (Mullins et al., 1991; Batra et al., 1991) . These studies did not show evidence of a neuroendocrine dierentiation of Panc-1 cells.
While wild-type p53 induced altered dierentiation of ductal pancreatic carcinoma cells to a neuroendocrine-like phenotype and apoptotic cell death are two plausible possibilities, it is still not clear why there are two outcomes of wild-type p53 reintroduction in this model system. A possible explanation for this dierence may be cell cycle dependent. While the cells were uniformally quiescent using serum-free media prior to experiments, it is still possible that cells were in dierent phases of the cell-cycle at the start of experiments. This could have a wide variety of eects, including a dierence in the p53 phosphorylation status. Cell cycle related proteins such as cdc2, and cdk2-cyclin A or cdk2-cyclin B have been shown to eect the phosphorylation status of p53 (Harris, 1996) . While the role of serine phosphorylation of the p53 protein in apoptosis and dierentiation is not understood, it has been shown to eect sequence-speci®c binding to the promoter regions of both the p21/ WAF1 and GADD45 genes (Harris, 1996) . Phosphorylation-dependent changes in the transcriptional ability of wt-p53 could modulate the activity to either an apoptotic or dierentiation pathway. In addition, cellular levels of wild-type p53 protein could also be playing a role. Recently, it was found that high levels of wild-type p53 induced apoptosis, while lower levels induced dierentiation in a wild-type p53 transfected HL-60 promyelocytic p53-null cell line (Ronen et al., 1996) . Both of these possibilities will be explored in future studies.
Therapeutic implications of stable wild-type p53 expression in ductal pancreatic carcinoma cells
Understanding the phenotypic consequence of reintroducing the wild-type p53 protein in a ductal pancreatic cancer model may aid in the future development of therapeutic strategies. With the majority of patients dying within a year of diagnosis, pancreatic cancer can be equivalent to a death sentence for these individuals (Reznek and Stephens, 1993) . However, even with this grim prognosis, little progress has been made in designing eective treatments. The aggressive metastatic dissemination of this cancer, and lack of early detection, led to a poor response to conventional surgical, chemo-and radiotherapies (Hall and Lemoine, 1993) . Because of this poor response, it would be advantageous to investigate alternative therapeutic possibilities.
Relatively few studies have examined alternative gene therapies for the treatment of pancreatic carcinoma, and studies speci®cally targeting p53 in ductal pancreatic cancer have been virtually unexplored. One study attempted to reduce the expression of the mutant p53 gene in six pancreatic carcinoma cell lines using antisense oligonucleotide strategies (Barton and Lemoine, 1995) . Both oligonucleotide strategies failed to suppress p53 protein production in a cell-free system, or suppress mutant p53 expression in pancreatic carcinoma cell lines (Barton and Lemoine, 1995) . Another study demonstrated that a human pancreatic adenocarcinoma cell line (HS700T), possessing a mutation in p53 (codon 249), is susceptible to cell death caused by infection of the E1B 55k de®cient mutant adenovirus (Dl1520) (Bischo et al., 1996) . A recent report (Kimura et al., 1997) described a retroviral transduction of a constitutively-expressed wild-type p53 into a pancreatic carcinoma cell line possessing an endogenous mutated p53 gene. This study found no eect on wild-type p53 transduction on in vitro growth, tumorigenicity, and chemosensitivity to several therapeutic agents. However, the authors did not unequivocally demonstrate the functionality of their transduced wild-type p53. In our present study, we examined transfection of a doublyinducible wild-type p53 gene in a pancreatic carcinoma cell culture model and its phenotypic consequences. The apoptotic response observed in the majority of these pancreatic ductal carcinoma cells, and the presence of growth-arrested`dierentiated' subpopulation, lead to optimistic hope of utilizing wild-type p53 gene therapeutic strategies in the treatment of pancreatic cancer. Since this cancer responds so poorly to traditional treatments, therapy that removes cancerous cells (by apoptosis) or partially restores function (by altered dierentiation) would be quite advantageous. In addition, since many patients suer from endocrine insuciency and diabetes as a secondary disease process of pancreatic carcinoma (Gullo et al., 1994) , restoration of a neuroendocrine phenotype would be bene®cial. However, these favorable responses to gene replacement therapy are speculative and theoretical, based solely on in vitro studies, and need to be explored further. Subsequent studies are in progress utilizing a xenotransplanted animal model of pancreatic carcinoma to explore the response of pancreatic carcinoma cells to stable wild-type p53 protein expression in an in vivo system. Furthermore, additional studies will focus on the phenotype of the stable`dierentiated' cell population upon xenotransplantation and orthotopic transplantation in nude mice.
In summary, stable transfection of an inducible wildtype p53 (MTmp53ts) expression vector into the human pancreatic ductal carcinoma cell line, Panc-1 leads to G 1 growth arrest, the induction of apoptosis, and possible altered cellular dierentiation in vitro. Ultrastructural analyses of these cell populations are currently in progress, as well as studies aimed at further characterizing the expression and regulation of neuroendocrine speci®c markers in this altered`dierentiated' phenotype. This temperature and metal induction system may be utilized to induce varying expression levels of exogenous wild-type p53 protein. This may alter the ratio between apoptotic and dierentiating populations, as it has been seen in other systems and cell types (Ronen et al., 1996) . Additionally, future studies will examine p53 related genes (such as p21, mdm2 and apoptotic genes bcl-2 and bax) and the Rb gene and determine how dierential expression of these genes are involved in the regulation of the processes of growth arrest, apoptosis, and dierentiation in this experimental model.
Materials and methods

Cell lines and transfection
The Panc-1 pancreatic carcinoma cell line was obtained from American Type Culture Collection (Rockville, MD) and maintained in Minimum Essential Media (MEM) (Gibco, Grand Island, NY) with 10% fetal bovine sera (Atlanta Biologicals). The cultures were incubated at 378C in 5% carbon dioxide. Two plasmids, SV-Neo (for G418 resistance) and MTmp53ts, were co-transfected into the cells by modi®ed calcium phosphate technique using BES buer as described (Ishiura et al., 1982) . The MTmp53ts vector is a metallothionein driven temperature-sensitive mouse expression vector (McNeall et al., 1989; Michalovitz et al., 1990) . MTmp53ts produces a p53 protein that displays a`mutant' phenotype that remains in the cell cytosol and is inactive at 378C. At 32.58C, the protein changes conformation to a`wild-type' phenotype that can enter the nucleus (Michalovitz et al., 1990) . The metal induced promoter is an altered hMTII A human promoter in which the basal level expression (BLE) elements have been replaced with additional metal responsive elements (MRE) (McNeall et al., 1989) . Stable transfectants were maintained in media containing 700 mg/ml G418. Cells were synchronized in serum-free conditions over-night before experiments.
Screening of clones
DNA from clones was isolated by standard proteinase K/ RNAse phenol chloroform extraction (Ruggeri et al., 1992) . The puri®ed DNA was screened for the transfected cDNA p53 insert by a PCR method (Yonish-Rouach et al., 1991) using 20mer oligonucleotides BRE6 (CCTCCT-CAGCATCTTATCCG) and BRE7 (GTGATGATGGT-GAGGATGGG). BRE6 is a sense primer in exon 6 and BRE7 is an antisense primer of exon 7 of p53. Since the ampli®cation area lies over an intron region, the ampli®ed DNA fragments are 701 base pairs for the endogenous p53 and 201 base pairs for the transfected p53 cDNA. Conditions for PCR were 35 cycles of 958C for 1.2 min, 508C for 1.2 min and 728C for 1.2 min, with 75 mM dNTP, 2 mM primer and 2.5 u Taq polymerase (Shaw et al., 1992) . The resulting ampli®ed fragments were then visualized on an agarose gel with ethidium bromide staining (Shaw et al., 1992) .
Immunohistochemical and Western blot analyses of p53 and p21/WAF1 expression in MTmp53ts transfected Panc-1 clones A Zinc kill curve was performed on the parental Panc-1 cells to determine optimum levels. The optimum concentration was determined to be 100 mM zinc chloride for one induction (McNeall et al., 1989) .
Twelve representative clones were chosen from the 60 screened clones. The clones and parental Panc-1 lines were subjected to zinc induction and a changed environmental temperature from 378C (the`mutant' phenotype of the p53 protein) to 32.58C (the`wild-type' phenotype of the p53 protein) (Michalovitz et al., 1990) . Protein lysates were collected in PBSTDS (1% Triton X-100 (v/v), 5% sodium deoxycholate (w/v), 0.1% SDS (v/v) in PBS) 2 and 6 h after zinc treatment. Protein lysates were also collected from cells that were left at 32.58C, with the absence of zinc to test the promoter for leakiness. In addition to the clones and parentals, other cell lines were tested as well; BPCC4A, a mouse skin carcinoma cell line expressing wild-type mouse p53 (positive controls) (Ruggeri et al., 1994) , and HL-60, a promyelocyte leukemia cell line that lacks endogenous p53 (negative control) (Soddu et al., 1994) . The cell lysates were immunoprecipitated following manufacturers protocol (Oncogene Science, Uniondale, NY) using cell counts (10 5 cells per sample) to quantitate rather than radioactive counts. Samples were precipitated with antibody pAB246 (Oncogene Science) which recognizes only murine wild-type p53. Immunoprecipitates were Western blotted using sheep polyclonal antiserum (Oncogene Science AB-7) according to manufacturer's speci®cations. Brie¯y, samples were electrophoresed on a 10% polyacrylamide gel (10 5 cells/well) and electrotransfered to a PVPF membrane (Immobilon, Bedford, MA). Membranes were blocked (10% non-fat dry milk in TBST blocking buer) overnight, then treated with anti-p53 sheep antisera Ab-7 for 2 h. Blots were incubated with peroxidase conjugated secondary IgG antibody and visualized by a chemiluminescence system according to manufacturer's instructions (Amersham, Buckinghamshire, England).
To supplement this data, cells were ®xed in chamberslides over a time-course (6, 8, 10, 12, 24 and 48 h) and p53 expression was checked in situ using immunohistochemistry. Cells were stained using p53 mouse monoclonal antibody clone 246 (Oncogene Science). Alternatively, the mammalian speci®c, wild-type p53 speci®c antibody 1620 (Oncogene Science) was also used in some experiments. Slides were then incubated with biotinylated secondary antibody, treated with streptavidin immunoperoxidase complex (Vectastain Elite ABC kit, Vector laboratories, Burlingame, CA), and stained with diaminobenzidine (DAB) chromagen.
Each of these experiments were done in triplicates utilizing cells grown in serum-free conditions for 12 h, then refed with 10% FBS.
To test the functionality of the insert, Western blotting of p21/WAF1 was performed (employing the same method as previously described) utilizing a mouse monoclonal antibody against p21/WAF1 (Oncogene Science Ab-1) (1 : 100 dilution) to assess the time course of wild-type p53 induced p21/WAF1 expression.
Cell growth and proliferation assays
Clones were grown with or without ZnCl 2 , and at 32.58C or 378C. Cells were counted using an inverted scope and hemocytometer at time-points of 0, 6, 12, 24, 48 and 120 h post induction. Cell proliferation was measured by 5-bromo-2'-deoxy-uridine (BrdU) incorporation using a labeling and detection kit (Boehringer Mannheim, Indianopolis, IN). Cells were grown on chamberslides, incubated with media containing BrdU (10 mM) for 1 h, and formalin ®xed over a time course (4, 6, 8, 10, 12, 24 and 48 h) . Cells were then treated with anti-BrdU mouse monoclonal antibody (clone BMC 9318, Boehringer Mannheim), incubated with anti-mouse-Ig-alkaline phosphatase, and stained with nitroblue tetrazolium (NBT) salt and Xphosphate chromagen.
Analysis of the apoptotic phenotype
Panc-1 parentals and transfected clone cells were grown either with inducing conditions (100 mM ZnCl 2 and 32.58C environment) or without (absence of ZnCl 2 and 378C environment) and observed over a time course of 48 h. Cell morphology was photographed in culture using a polaroid microcam instant camera.
Internucleosomal laddering was detected in situ utilizing an Apoptag kit (Oncor, Gaithersburg, MD). Cells were ®xed on chamberslides over a 48 h time-course. DNA nucleosomal laddering was in situ end labeled by TdT enzyme with digoxigenin-nucleotide. These nucleotides were bound to antidigoxigenin antibody peroxidase conjugate, then stained with diaminobenzidine (DAB) chromagen.
DNA was isolated from transfected clones at 0, 8 and 24 h post-induction by standard proteinase K/RNAse phenol chloroform extraction (Ruggeri et al., 1992) using extra care to prevent DNA shearing. The resulting DNA was electrophoresed on a 1.5% agarose gel, stained with ethidium bromide and visualized for internucleosomal DNA laddering (Wyllie, 1980) .
Flow cytometry
The cell cycle parental Panc-1 and MTmp53ts clone cells were analysed utilizing¯ow cytometry with or without the presence of zinc. At timepoints of 0, 3, 9, 12 and 24 h, 10 6 cells were trypsinized, then centrifuged at 1000 r.p.m. Pellets were resuspended in stain solutions (3% w/v PEG 8000, 50 mg/ml propidium iodide (PI), 0.1% Triton-X, and 360 U/ml RNAse A (Qiagen, Chatsworth, CA) in 4 mM citrate buer, pH 7.2) and incubated for 30 min at 378C. Volumes of samples were doubled with salt solution (3% PEG 8000, 50 mg/ml PI, and 0.1% Triton X in 0.4 M NaCl, pH 7.2). Samples were then stored in the dark overnight. DNA content was detected by PI¯uorescence using a FACS analyser (Becton Dickson FACScan).
Immunochemical and Western blot analyses of neuroendocrineassociated markers in stable MTmp53ts transfectants
MTmp53ts transfected cells, parental Panc-1 cells (negative control) and PC12 cells (positive controls, obtained from American Type Culture Collection) were ®xed in chamberslides 24 h post ZnCl 2 /32.58C induction. Cells were stained using tau-2 mouse monoclonal antibody (Wang et al., 1993) . (1 : 1000 dilution), or synaptophysin (Dako Corp, Carpinteria, CA, antibody clone A010) (1 : 100 dilution) and chromogranin A (Dako Corp, Ab clone A430) (1 : 100 dilution), rabbit polyclonal antibodies. Slides were developed and stained as described previously for p53.
To support this data, cell pellets were collected over a time-course (0, 0.5, 1, 2, 4, 6, 8, 10, 12, 24, 72 and 170 h post ZnCl 2 /32.58C induction). Pellets were resuspended in Laemmli buer (63 mM Tris-HCl, 10% glycerol, 5% bmercaptoethanol, 2% SDS, 0.025% bromphenol blue), electrophoresed on a 10 ± 20% polyacrylamide gradient gel, and electrotransferred to a PVPF membrane (Immobilon). The antibodies utilized and dilutions for tau and synaptophysin were the same as those used in immunohistochemistry, while chromagranin A (Vector Laboratories, clone LK2H10) was used at a 1 : 50 dilultion. All other conditions performed following previously described for the p53 Western blotting.
